Position in PMVP
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$265
-$2 QoQ
Shares Held
214
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. PMVP ranks #355 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in PMVP
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $265 | 214 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $267 | 214 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,279 | 914 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $968 | 914 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $12,479 | 11,449 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $37,132 | 24,591 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,536 | 1,032 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $324,882 | 200,545 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $202,756 | 119,269 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $12,184,052 | 3,930,340 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $24,767,044 | 4,033,721 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $25,512,652 | 4,075,504 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $19,093,754 | 4,002,884 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $35,639,992 | 4,096,551 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $56,002,576 | 4,706,099 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $70,100,351 | 4,919,323 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $66,738,238 | 3,205,487 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $73,162,827 | 3,167,222 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $53,851,340 | 1,807,092 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $56,127,064 | 1,643,064 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $30,764,975 | 935,390 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,281,958 | 37,099 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $355,000 | 10,000 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||